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With the launch of Women’s Midlife Health, we seek to
stimulate increased scientific and clinical focus on the
midlife and its relevance to health and healthy aging.
Over the past two decades, several cohort studies have
advanced scientific understanding of the natural history
of ovarian aging and begun to elucidate the inter-
relationship between ovarian aging and, for example,
bone, cardiovascular, cognitive, and musculoskeletal
health. Notably, these studies have also shed light on
age-related changes that occur in midlife independent of
ovarian aging. Critical insights include observations that
bone loss, osteoarthritis, adverse changes in lipid pro-
files, diabetes, metabolic syndrome, and sleep distur-
bances frequently begin and/or accelerate during the
midlife period – in some cases accelerated by the endo-
crine changes associated with the menopause and in
others simply coincident with them. It is apparent that
healthy behaviors in midlife, such as maintenance of
physical activity and healthy body weight may moderate
these changes. Furthermore, it is increasingly recognized
that healthy lifestyles and control of vascular risk factors
in midlife may be beneficial for cognitive health in later
years. Thus, the evidence strongly suggests that the mid-
life represents a critical window for preventing chronic
disease and optimizing health and functioning.
In addition to symptoms that are the hall mark of
menopause, i.e. vasomotor symptoms or “hotflashes”, sev-
eral health conditions peak or are exacerbated during the
midlife, including fibroids and consequent hysterectomies,
migraine and systemic lupus erythematosus. Thus the
midlife also warrants attention as a vulnerable window for
an important subset of gynecologic and hormone-sensitive
conditions.
We define the midlife as beginning at about age 35–40
years and extending to about age 60–65 years. This age
range encompasses the late reproductive to late post-
menopausal stages of reproductive aging [1–4]. Thus,
for women, it includes the menopausal transition and
post-menopause up through the age where, presumably,
ovarian senescence is no longer actively influencing the
aging process. Studies of aging have typically focused on
and enrolled participants aged 60 or 65 and older, an age
when the window of opportunity for primary prevention
may well have been missed. While prevention and
healthy lifestyles are important at all ages, it is increas-
ingly apparent that health in midlife is an important de-
terminant of a healthy and fully functional life in the
following decades.
For example, the mid-life appears to be a vulnerable
window for onset of functional limitations and the tran-
sition to disability. Up to one quarter of recently meno-
pausal women report having substantial functional
limitations. Mobility-based disabilities are highly preva-
lent, with one midlife cohort reporting that 39 % of
women reported moderate to extreme difficulty in mo-
bility as measured by the World Health Organization
Disability Assessment Schedule [5]. Declines in function-
ing during this life-stage may be related to the acceler-
ation of other adverse changes in the midlife including
the onset of metabolic syndrome and diabetes, adverse
changes in lipid profiles, hearing and vision, and body
composition changes but may also be a direct result of
the onset of osteoarthritis. In one of few prospective
studies that included midlife women, two-thirds had evi-
dence of osteoarthritis, the leading cause of pain and
adult disability in the United States, in the early post-
menopause (mean age 57 years) [6].
Risk of osteoporosis and, concomitantly, fracture in-
creases with aging and it has long been understood that
bone loss is associated with menopause. The midlife co-
hort studies have now documented that bone loss begins
prior to the final menstrual period with an accelerated
period of loss in bone mineral density and bone strength
beginning 1–2 years before menopause until 2–5 years
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into the post-menopause[7]. As it is estimated that about
half of the lifetime loss in bone mineral density occurs
during this relatively short period in the midlife, it repre-
sents a critical period for interventions to optimize re-
ductions in the loss of bone strength.
The Women’s Health Initiative refocused attention on
the midlife as potentially a vulnerable window for inter-
ventions to protect heart health with a call for increased
research on change in women’s cardiovascular risk profile
during the menopausal transition. Recent studies support
the hypothesis that increase in cardiovascular risk acceler-
ates with ovarian aging. The Study of Women’s Health
Across the Nation has documented that levels of total
cholesterol, low density lipoprotein and apolipoprotein B,
increase significantly in the 2-year window around the
menopause [8] as do adverse changes in measures of aor-
tic calcification during the late menopausal transition [9].
Notably, emerging evidence suggests that the hallmark
menopausal symptom, the hotflash, is associated with in-
creased cardiovascular risk profiles [10] with several
ongoing studies working to identify the mechanisms
underlying these associations. Ongoing studies will pro-
vide data regarding the trajectories of these changes in
cardiovascular risk in late post-menopause.
Understanding depression risk across the life-course
also requires increased insight into the changes in risk
that occur at midlife. Approximately 20-30 % of mid-life
women experience incident or recurrent episodes of
clinical depression, the leading cause of health-related
disability in women. Fluctuations in reproductive hor-
mones associated with ovarian aging are one potential
mechanism underlying midlife risk, however, other
menopause-associated physiological and psychosocial
changes including increased prevalence of sleep distur-
bances likely also play a role.
In sum the relative lack of attention to midlife health
ignores the evidence that critical changes are occurring
during this life-stage that warrant changes in lifestyle,
behavior, social engagement and health care practices.
As suggested by the old saying – At 40, your eyesight
starts to go; at 50 everything else starts to go – the
midlife is a period of substantial physiologic change
that requires adaptive change to optimize health and
functioning. The goal of Women’s Midlife Health is to
provide a forum for increased scientific inquiry into the
mechanisms that underlie the physiologic changes of
the midlife, the triggers for and nature of the aging-and
ovarian-aging related processes that are initiated during
this life-stage, and the critical factors, particularly
modifiable ones, that influence the risk of healthy
versus unhealthy aging. Given the increasing wealth of
knowledge about the impact of ovarian senescence, re-
search on non-ovarian triggers of symptomatic and
non-symptomatic aging-related physiologic changes is a
specific priority. Comparative studies of the midlife in
men are also warranted.
Notably, data on the midlife are particularly scant from
low and middle income countries, where optimizing
health during this life-stage will be critical to enhancing
life expectancy and reducing disability. Evaluation of
context specific health risks more common in such
settings, such as the impact of late childbirth and life-
long under-nutrition, is warranted. Also lacking are data
regarding racial/ethnic differences in midlife health, and
whether trajectories of change during the menopause
transition differ.
Women’s Midlife Health welcomes clinical and
population-based research that provides new insights
into the health transitions that occur during midlife
and with menopause, with a particular interest in
articles addressing vulnerabilities and opportunities
during this life stage and addressing interventions that
promote a healthy transition and healthy aging. Man-
uscripts that consider the impact of the environment
and occupation, areas frequently ignored in studies of
women, as well as gender-specific social factors on
health and disease processes during this life-stage are
encouraged.
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